![Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people - The Lancet Healthy Longevity Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/bbd58d40-5b11-4ad5-9ff4-fea1865f9c31/gr1.gif)
Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people - The Lancet Healthy Longevity
![Investor's Guide To Clinical Trials: Phase Success Rates For Introductory Pipeline Analysis | Seeking Alpha Investor's Guide To Clinical Trials: Phase Success Rates For Introductory Pipeline Analysis | Seeking Alpha](https://static.seekingalpha.com/uploads/2017/3/2/30035385-14884880904879966.jpg)
Investor's Guide To Clinical Trials: Phase Success Rates For Introductory Pipeline Analysis | Seeking Alpha
![An empirical assessment of research practices across 163 clinical trials of tumor-bearing companion dogs | Scientific Reports An empirical assessment of research practices across 163 clinical trials of tumor-bearing companion dogs | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-48425-5/MediaObjects/41598_2019_48425_Fig1_HTML.png)
An empirical assessment of research practices across 163 clinical trials of tumor-bearing companion dogs | Scientific Reports
![Recruitment of Black Adults into Cardiovascular Disease Trials | Journal of the American Heart Association Recruitment of Black Adults into Cardiovascular Disease Trials | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/13ef21df-50f4-4ed9-b7c8-0a8329ca19d2/jah36522-fig-0001.png)
Recruitment of Black Adults into Cardiovascular Disease Trials | Journal of the American Heart Association
![A Guide to Understanding Clinical Trials: Part 2 - Five Factors to Consider When Evaluating Results - Bench Press A Guide to Understanding Clinical Trials: Part 2 - Five Factors to Consider When Evaluating Results - Bench Press](https://i0.wp.com/mgriblog.org/wp-content/uploads/2020/06/MGRI-Clinical-trials-explainer-Insta-01-1.png?resize=1024%2C1024&ssl=1)
A Guide to Understanding Clinical Trials: Part 2 - Five Factors to Consider When Evaluating Results - Bench Press
![Frontiers | Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials Frontiers | Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials](https://www.frontiersin.org/files/MyHome%20Article%20Library/447872/447872_Thumb_400.jpg)
Frontiers | Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials
![Are cancer patients better off if they participate in clinical trials? A mixed methods study | BMC Cancer | Full Text Are cancer patients better off if they participate in clinical trials? A mixed methods study | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-06916-z/MediaObjects/12885_2020_6916_Fig1_HTML.png)
Are cancer patients better off if they participate in clinical trials? A mixed methods study | BMC Cancer | Full Text
![Prototype of running clinical trials in an untrustworthy environment using blockchain | Nature Communications Prototype of running clinical trials in an untrustworthy environment using blockchain | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-08874-y/MediaObjects/41467_2019_8874_Fig1_HTML.png)
Prototype of running clinical trials in an untrustworthy environment using blockchain | Nature Communications
![Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet](https://www.thelancet.com/cms/asset/04f3d1bc-8493-4bfa-9572-fc2f5606352f/gr1.jpg)
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet
![A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine](https://www.thelancet.com/cms/asset/d21a79d0-e889-4023-b8d7-d3a07e2cf38d/gr1.jpg)